List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Asia Pacific In Vitro Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Asia Pacific In Vitro Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of Asia Pacific In Vitro Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific In Vitro Diagnostics Market 39
Figure 13. Breakdown of Asia Pacific In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. Asia Pacific In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 45
Figure 16. Asia Pacific In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 46
Figure 17. Asia Pacific In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 47
Figure 18. Asia Pacific In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 48
Figure 19. Asia Pacific In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 49
Figure 20. Breakdown of Asia Pacific In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 21. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 22. Asia Pacific In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 52
Figure 23. Asia Pacific In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 53
Figure 24. Asia Pacific In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 54
Figure 25. Asia Pacific In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 55
Figure 26. Asia Pacific In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 56
Figure 27. Asia Pacific In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 57
Figure 28. Asia Pacific In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 58
Figure 29. Asia Pacific In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 59
Figure 30. Asia Pacific In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 60
Figure 31. Breakdown of Asia Pacific In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 62
Figure 32. Asia Pacific Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 62
Figure 33. Asia Pacific In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 63
Figure 34. Asia Pacific In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 64
Figure 35. Asia Pacific In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 65
Figure 36. Asia Pacific In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 66
Figure 37. Breakdown of Asia Pacific In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 68
Figure 38. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 68
Figure 39. Asia Pacific In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 69
Figure 40. Asia Pacific In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 79
Figure 41. Asia Pacific In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 80
Figure 42. Asia Pacific In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 81
Figure 43. Asia Pacific In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 82
Figure 44. Asia Pacific In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 83
Figure 45. Asia Pacific In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 84
Figure 46. Asia Pacific In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 85
Figure 47. Asia Pacific In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 86
Figure 48. Breakdown of Asia Pacific In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 88
Figure 49. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 88
Figure 50. Asia Pacific In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 89
Figure 51. Asia Pacific In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 90
Figure 52. Asia Pacific In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 91
Figure 53. Asia Pacific In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 92
Figure 54. Asia Pacific In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 93
Figure 55. Breakdown of APAC In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 95
Figure 56. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57. In Vitro Diagnostics Market in Japan, 2021-2031, $ mn 98
Figure 58. In Vitro Diagnostics Market in China, 2021-2031, $ mn 100
Figure 59. In Vitro Diagnostics Market in Australia, 2021-2031, $ mn 102
Figure 60. In Vitro Diagnostics Market in India, 2021-2031, $ mn 104
Figure 61. In Vitro Diagnostics Market in South Korea, 2021-2031, $ mn 106
Figure 62. In Vitro Diagnostics Market in Rest of APAC, 2021-2031, $ mn 108
Figure 63. Growth Stage of Asia Pacific In Vitro Diagnostics Industry over the Forecast Period 110
Asia Pacific in vitro diagnostics (IVD) market will grow by 7.8% annually with a total addressable market cap of $303,673.6 million over 2022-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 35 tables and 64 figures, this 138-page report “Asia Pacific In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments & Devices o Disposable IVD Devices o Reusable IVD Devices • Reagents & Kits • Software & Services Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Chemistry • Molecular Diagnostics • Immuno Diagnostics • Hematology • Tissue Diagnostics • Microbiology • Coagulation and Hemostasis • Urinalysis • Other Technologies By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood • Mucus • Urine • Other Sample Types By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Infectious Diseases • Diabetes • Cancer/Oncology • Cardiology • Autoimmune Disease • Nephrology • Drug Testing • HIV/AIDS • Other Applications By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Laboratories • Hospitals and Clinics • Homecare Settings • Point-of-Care (POC) Settings • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories, Inc. Agilent Technologies, Inc. Arkray Inc. Becton, Dickinson and Company Biomerieux SA Bio-Rad Laboratories Inc. Danaher Corporation DiaSorin SpA (Luminex Corporation) Epic Systems Corporation F. Hoffmann-La Roche Ltd. Genpact Limited Grifols SA IBM Corporation Mckesson Corporation Ortho Clinical Diagnostics Inc. Qiagen NV Quest Diagnostics Inc. Quidel Corporation Roche Diagnostics Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More